Functional Brain PET Imaging Effectively Forecasts Which Vegetative Patients Can Recover Consciousness
By MedImaging International staff writers Posted on 27 Apr 2014 |

Image: A functional brain imaging technique known as positron emission tomography (PET) is a promising tool for determining which severely brain damaged individuals in vegetative states have the potential to recover consciousness (Photo courtesy of sonap / Fotolia).
Positron emission tomography (PET) has the potential for determining which brain damaged individuals in vegetative states have the potential to recover consciousness, according to new research.
The study’s findings were published online April 16, 2014, in the Lancet. It is the first time that researchers have assessed the diagnostic accuracy of functional brain imaging techniques in clinical practice. “Our findings suggest that PET imaging can reveal cognitive processes that aren’t visible through traditional bedside tests, and could substantially complement standard behavioral assessments to identify unresponsive or ‘vegetative’ patients who have the potential for long-term recovery,” stated study leader Prof. Steven Laureys, from the University of Liége (Belgium).
In severely brain-damaged individuals, judging the level of consciousness has proved challenging. Traditionally, bedside clinical examinations have been used to decide whether patients are in a minimally conscious state (MCS), in which there is some evidence of awareness and response to stimuli, or are in a vegetative state (VS) also known as unresponsive wakefulness syndrome, where there is neither, and the chance of recovery is much lower. But up to 40% of patients are misdiagnosed using these scans.
“In patients with substantial cerebral edema, prediction of outcome on the basis of standard clinical examination and structural brain imaging is probably little better than flipping a coin,” wrote Jamie Sleigh from the University of Auckland (New Zealand), and Catherine Warnaby from the University of Oxford (UK), in a linked comment.
The study evaluated whether two new functional brain imaging techniques—PET with the imaging agent fluorodeoxyglucose (FDG) and functional MRI (fMRI) during mental imagery tasks—could differentiate between vegetative and MCS in 126 patients with severe brain injury (81 in a MCS, 41 in a VS, and four with locked-in syndrome—a behaviorally unresponsive but conscious control group) referred to the University Hospital of Liége, from across Europe. The researchers then compared their results with the well-established standardized Coma Recovery Scale-Revised (CSR-R) behavioral test, considered the most confirmed and sensitive technique for discriminating very low awareness.
FDG-PET was better overall than fMRI in differentiating conscious from unconscious patients. Mental imagery fMRI was less sensitive at diagnosis of a MCS than FDG-PET (45% vs. 93%), and had less agreement with behavioral CRS-R scores than FDG-PET (63% vs. 85%). FDG-PET was about 74% accurate in predicting the extent of recovery within the next year, compared with 56% for fMRI.
Significantly, one-third of the 36 patients diagnosed as behaviorally unresponsive on the CSR-R test who were scanned with FDG-PET showed brain activity consistent with the presence of some consciousness. Nine patients in this group consequently recovered a reasonable level of consciousness.
According to Prof. Laureys, “We confirm that a small but substantial proportion of behaviorally unresponsive patients retain brain activity compatible with awareness. Repeated testing with the CRS-R complemented with a cerebral FDG-PET examination provides a simple and reliable diagnostic tool with high sensitivity towards unresponsive but aware patients. fMRI during mental tasks might complement the assessment with information about preserved cognitive capability, but should not be the main or sole diagnostic imaging method.”
The authors noted that the study was conducted in a specialist unit focusing on the diagnostic neuroimaging of disorders of consciousness and therefore deployment might be more challenging in less specialist units.
Commenting on the study Drs. Sleigh and Warnaby added, “From these data, it would be hard to sustain a confident diagnosis of unresponsive wakefulness syndrome solely on behavioral grounds, without PET imaging for confirmation ... [This] work serves as a signpost for future studies. Functional brain imaging is expensive and technically challenging, but it will almost certainly become cheaper and easier. In the future, we will probably look back in amazement at how we were ever able to practice without it.”
Related Links:
University of Liége
The study’s findings were published online April 16, 2014, in the Lancet. It is the first time that researchers have assessed the diagnostic accuracy of functional brain imaging techniques in clinical practice. “Our findings suggest that PET imaging can reveal cognitive processes that aren’t visible through traditional bedside tests, and could substantially complement standard behavioral assessments to identify unresponsive or ‘vegetative’ patients who have the potential for long-term recovery,” stated study leader Prof. Steven Laureys, from the University of Liége (Belgium).
In severely brain-damaged individuals, judging the level of consciousness has proved challenging. Traditionally, bedside clinical examinations have been used to decide whether patients are in a minimally conscious state (MCS), in which there is some evidence of awareness and response to stimuli, or are in a vegetative state (VS) also known as unresponsive wakefulness syndrome, where there is neither, and the chance of recovery is much lower. But up to 40% of patients are misdiagnosed using these scans.
“In patients with substantial cerebral edema, prediction of outcome on the basis of standard clinical examination and structural brain imaging is probably little better than flipping a coin,” wrote Jamie Sleigh from the University of Auckland (New Zealand), and Catherine Warnaby from the University of Oxford (UK), in a linked comment.
The study evaluated whether two new functional brain imaging techniques—PET with the imaging agent fluorodeoxyglucose (FDG) and functional MRI (fMRI) during mental imagery tasks—could differentiate between vegetative and MCS in 126 patients with severe brain injury (81 in a MCS, 41 in a VS, and four with locked-in syndrome—a behaviorally unresponsive but conscious control group) referred to the University Hospital of Liége, from across Europe. The researchers then compared their results with the well-established standardized Coma Recovery Scale-Revised (CSR-R) behavioral test, considered the most confirmed and sensitive technique for discriminating very low awareness.
FDG-PET was better overall than fMRI in differentiating conscious from unconscious patients. Mental imagery fMRI was less sensitive at diagnosis of a MCS than FDG-PET (45% vs. 93%), and had less agreement with behavioral CRS-R scores than FDG-PET (63% vs. 85%). FDG-PET was about 74% accurate in predicting the extent of recovery within the next year, compared with 56% for fMRI.
Significantly, one-third of the 36 patients diagnosed as behaviorally unresponsive on the CSR-R test who were scanned with FDG-PET showed brain activity consistent with the presence of some consciousness. Nine patients in this group consequently recovered a reasonable level of consciousness.
According to Prof. Laureys, “We confirm that a small but substantial proportion of behaviorally unresponsive patients retain brain activity compatible with awareness. Repeated testing with the CRS-R complemented with a cerebral FDG-PET examination provides a simple and reliable diagnostic tool with high sensitivity towards unresponsive but aware patients. fMRI during mental tasks might complement the assessment with information about preserved cognitive capability, but should not be the main or sole diagnostic imaging method.”
The authors noted that the study was conducted in a specialist unit focusing on the diagnostic neuroimaging of disorders of consciousness and therefore deployment might be more challenging in less specialist units.
Commenting on the study Drs. Sleigh and Warnaby added, “From these data, it would be hard to sustain a confident diagnosis of unresponsive wakefulness syndrome solely on behavioral grounds, without PET imaging for confirmation ... [This] work serves as a signpost for future studies. Functional brain imaging is expensive and technically challenging, but it will almost certainly become cheaper and easier. In the future, we will probably look back in amazement at how we were ever able to practice without it.”
Related Links:
University of Liége
Latest Nuclear Medicine News
- New Camera Sees Inside Human Body for Enhanced Scanning and Diagnosis
- Novel Bacteria-Specific PET Imaging Approach Detects Hard-To-Diagnose Lung Infections
- New Imaging Approach Could Reduce Need for Biopsies to Monitor Prostate Cancer
- Novel Radiolabeled Antibody Improves Diagnosis and Treatment of Solid Tumors
- Novel PET Imaging Approach Offers Never-Before-Seen View of Neuroinflammation
- Novel Radiotracer Identifies Biomarker for Triple-Negative Breast Cancer
- Innovative PET Imaging Technique to Help Diagnose Neurodegeneration
- New Molecular Imaging Test to Improve Lung Cancer Diagnosis
- Novel PET Technique Visualizes Spinal Cord Injuries to Predict Recovery
- Next-Gen Tau Radiotracers Outperform FDA-Approved Imaging Agents in Detecting Alzheimer’s
- Breakthrough Method Detects Inflammation in Body Using PET Imaging
- Advanced Imaging Reveals Hidden Metastases in High-Risk Prostate Cancer Patients
- Combining Advanced Imaging Technologies Offers Breakthrough in Glioblastoma Treatment
- New Molecular Imaging Agent Accurately Identifies Crucial Cancer Biomarker
- New Scans Light Up Aggressive Tumors for Better Treatment
- AI Stroke Brain Scan Readings Twice as Accurate as Current Method
Channels
Radiography
view channel
AI Hybrid Strategy Improves Mammogram Interpretation
Breast cancer screening programs rely heavily on radiologists interpreting mammograms, a process that is time-intensive and subject to errors. While artificial intelligence (AI) models have shown strong... Read more
AI Technology Predicts Personalized Five-Year Risk of Developing Breast Cancer
Breast cancer remains one of the most common cancers among women, with about one in eight receiving a diagnosis in their lifetime. Despite widespread use of mammography, about 34% of patients in the U.... Read moreMRI
view channel
AI-Assisted Model Enhances MRI Heart Scans
A cardiac MRI can reveal critical information about the heart’s function and any abnormalities, but traditional scans take 30 to 90 minutes and often suffer from poor image quality due to patient movement.... Read more
AI Model Outperforms Doctors at Identifying Patients Most At-Risk of Cardiac Arrest
Hypertrophic cardiomyopathy is one of the most common inherited heart conditions and a leading cause of sudden cardiac death in young individuals and athletes. While many patients live normal lives, some... Read moreUltrasound
view channel
Non-Invasive Ultrasound-Based Tool Accurately Detects Infant Meningitis
Meningitis, an inflammation of the membranes surrounding the brain and spinal cord, can be fatal in infants if not diagnosed and treated early. Even when treated, it may leave lasting damage, such as cognitive... Read more
Breakthrough Deep Learning Model Enhances Handheld 3D Medical Imaging
Ultrasound imaging is a vital diagnostic technique used to visualize internal organs and tissues in real time and to guide procedures such as biopsies and injections. When paired with photoacoustic imaging... Read moreGeneral/Advanced Imaging
view channel
Cutting-Edge Angio-CT Solution Offers New Therapeutic Possibilities
Maintaining accuracy and safety in interventional radiology is a constant challenge, especially as complex procedures require both high precision and efficiency. Traditional setups often involve multiple... Read more
Extending CT Imaging Detects Hidden Blood Clots in Stroke Patients
Strokes caused by blood clots or other mechanisms that obstruct blood flow in the brain account for about 85% of all strokes. Determining where a clot originates is crucial, since it guides safe and effective... Read more
Groundbreaking AI Model Accurately Segments Liver Tumors from CT Scans
Liver cancer is the sixth most common cancer worldwide and a leading cause of cancer-related deaths. Accurate segmentation of liver tumors is critical for diagnosis and therapy, but manual methods by radiologists... Read more
New CT-Based Indicator Helps Predict Life-Threatening Postpartum Bleeding Cases
Postpartum hemorrhage (PPH) is a leading cause of maternal death worldwide. While most cases can be controlled with medications and basic interventions, some become life-threatening and require invasive treatments.... Read moreImaging IT
view channel
New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible
Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more
Global AI in Medical Diagnostics Market to Be Driven by Demand for Image Recognition in Radiology
The global artificial intelligence (AI) in medical diagnostics market is expanding with early disease detection being one of its key applications and image recognition becoming a compelling consumer proposition... Read moreIndustry News
view channel
GE HealthCare and NVIDIA Collaboration to Reimagine Diagnostic Imaging
GE HealthCare (Chicago, IL, USA) has entered into a collaboration with NVIDIA (Santa Clara, CA, USA), expanding the existing relationship between the two companies to focus on pioneering innovation in... Read more
Patient-Specific 3D-Printed Phantoms Transform CT Imaging
New research has highlighted how anatomically precise, patient-specific 3D-printed phantoms are proving to be scalable, cost-effective, and efficient tools in the development of new CT scan algorithms... Read more
Siemens and Sectra Collaborate on Enhancing Radiology Workflows
Siemens Healthineers (Forchheim, Germany) and Sectra (Linköping, Sweden) have entered into a collaboration aimed at enhancing radiologists' diagnostic capabilities and, in turn, improving patient care... Read more